aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Abridge was founded with the mission to enhance healthcare communication by leveraging advanced AI technology. The company aims to help patients and clinicians capture and understand the details of their medical conversations, ensuring effective follow-through on healthcare recommendations. Abridge offers an AI platform that transforms patient-clinician dialogues into structured clinical notes in real-time, significantly reducing the documentation burden on healthcare providers. Their services are integrated directly within Epic, a widely used electronic health record system, focusing on improving efficiency and accuracy across over 50 medical specialties.
Notable figures associated with Abridge include its founders and key investors who have backgrounds in both healthcare and technology. The company has achieved significant milestones, such as saving clinicians over 70 hours of documentation time per month and providing clinically accurate summaries across numerous specialties. Abridge's impact is evident in its ability to streamline healthcare workflows, enhance patient understanding, and improve overall care delivery through innovative AI solutions.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Ai Platform, Healthcare
Technology
AI, Machine Learning
Tags
Healthtech, SaaS
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Abridge founded?
Abridge was founded in 2018.
Where is Abridge’s headquarters located?
Abridge’s headquarters is located in Pittsburgh, PA, US.
When was Abridge’s last funding round?
Abridge’s most recent funding round was for $30M (USD) in October 2023.
How many employees does Abridge have?
Abridge has 35 employees as of Feb 4, 2024.
How much has Abridge raised to-date?
As of July 05, 2023, Abridge has raised a total of $57.5M (USD) since Oct 26, 2023.
Add Comparison
Total Raised to Date
$57.5M
USD
Last Update Oct 26, 2023
Last Deal Details
$30M
USD
Oct 26, 2023
Series B
Total Employees Over Time
35
As of Feb 2024
Abridge Address
Pittsburgh,
Pennsylvania
15232
United States
TechCrunch
Here’s the full list of 28 US AI startups that have raised $100M or more in 2024
In the first half of 2024 alone, more than $35.5 billion was invested into AI startups globally. © 2024 TechCrunch. All rights reserved....
Jul 13, 2024
Is this the right Abridge?
Help us improve our AI - Is this article for the right company?
TechCrunch
10 of the most exciting digital health startups of 2024, according to VCs
In the post-COVID world, VCs say it’s not as easy to get excited about investing in digital health. Deal activity in healthcare IT was...
Jun 25, 2024
Is this the right Abridge?
Help us improve our AI - Is this article for the right company?
TechCrunch
How Abridge became one of the most talked about healthcare AI startups
Ask any of the health-focused VCs to name one of the top AI startups and one name comes up over and over again: a company based in...
Jun 19, 2024
Is this the right Abridge?
Help us improve our AI - Is this article for the right company?
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts